Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1161/CIRCRESAHA.120.317450 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease.
World J Gastrointest Pharmacol Ther
November 2024
Department of Gastroenterology, St. Luke's University Health Network, Bethlehem, PA 18015, United States.
Background: Inflammatory bowel disease (IBD), with its rising prevalence rates is associated with an increased risk of cardiovascular and thromboembolic events. Antiplatelets and/or anticoagulants agents are often prescribed but the literature on the impact of long-term anticoagulation and/or antiplatelet use among patients hospitalized with IBD is scarce. The aim of this study is to assess the outcomes of patients hospitalized with IBD on antiplatelet and/or anticoagulant agents.
View Article and Find Full Text PDFPractice patterns of antiplatelet and anticoagulant therapy after fenestrated/branched endovascular aortic repair.
J Vasc Surg
October 2024
University of Massachusetts, Worcester, MA. Electronic address:
Objective: Antiplatelet and/or anticoagulant therapy are commonly prescribed after fenestrated/branched endovascular aortic repair (F/BEVAR). However, the optimal regimen remains unknown. We sought to characterize practice patterns and outcomes of antiplatelet and anticoagulant use in patients who underwent F/BEVAR.
View Article and Find Full Text PDFAssessment of Blood Loss during Neuroendovascular Procedures.
J Clin Med
January 2024
Department of Neurosurgery, University of Florida, Gainesville, FL 32601, USA.
(1) Background: Neuroendovascular procedures have generally been considered to have minor or inconsequential blood loss. No study, however, has investigated this question. The purpose of this study is to quantify the blood loss associated with neuroendovascular procedures and identify predictors of blood loss, using hemoglobin change as a surrogate for blood loss.
View Article and Find Full Text PDFThe Neurosurgeon's Dilemma-Do Antiplatelet/Anticoagulant Medications Increase the Risk of Catheter-Associated Hemorrhage in External Ventricular Drain Placement?
World Neurosurg
February 2024
Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Objective: External ventricular drain (EVD) placement is a common neurosurgical procedure that can be performed at bedside. A frequent complication following EVD placement is catheter-associated hemorrhage (CAH). The hemorrhage itself is rarely clinically significant but may be complicated in patients taking anticoagulant or antiplatelet (AC/AP) medications.
View Article and Find Full Text PDFSclerobanding in the treatment of second and third degree hemorrhoidal disease in high risk patients on antiplatelet/anticoagulant therapy without suspension: a pilot study.
Front Surg
November 2023
Coloproctology Centre, Clinica del Mediterraneo, Ragusa, Italy.
Introduction: Around 20% of population in western countries is under anticoagulant treatment. However, there is paucity of evidence about the treatment of HD in patients under anticoagulant/antiplatelet therapy, although both suspension and continuation in the perioperative period may increase the risk of severe complications. The aim of this pilot study was to confirm the feasibility and safety of sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy), an office-based procedure, for the treatment of second-and third-degree HD in patients under anticoagulant/antiplatelet therapy without suspension.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!